Biotech Company Regeneron to buy bankrupt 23andMe for $ 256 million
Biotechnology company Regeneron will acquire 23andMe from bankruptcy for $ 256 million, with a plan to keep the DNA test company without interruption and to… Read More »Biotech Company Regeneron to buy bankrupt 23andMe for $ 256 million